UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
quizartinib (53) 53
life sciences & biomedicine (43) 43
science & technology (43) 43
acute myeloid leukemia (26) 26
humans (26) 26
flt3 (22) 22
leukemia (22) 22
oncology (19) 19
leukemia, myeloid, acute - drug therapy (17) 17
mutation (17) 17
hematology (16) 16
fms-like tyrosine kinase 3 - genetics (15) 15
fms-like tyrosine kinase 3 - antagonists & inhibitors (14) 14
pharmacology & pharmacy (14) 14
sorafenib (14) 14
aml (11) 11
gilteritinib (11) 11
midostaurin (11) 11
kinases (10) 10
tyrosine (10) 10
animals (9) 9
chemotherapy (9) 9
flt3 inhibitor (9) 9
fms-like tyrosine kinase 3 - metabolism (9) 9
hemic and lymphatic diseases (9) 9
antineoplastic agents - therapeutic use (8) 8
benzothiazoles - therapeutic use (8) 8
cancer (8) 8
crenolanib (8) 8
embryonic structures (8) 8
leukemia, myeloid, acute - genetics (8) 8
phenylurea compounds - therapeutic use (8) 8
protein kinase inhibitors - pharmacology (8) 8
benzothiazoles - pharmacology (7) 7
phenylurea compounds - pharmacology (7) 7
protein kinase inhibitors - therapeutic use (7) 7
recurrence (7) 7
antineoplastic agents - pharmacology (6) 6
clinical trials (6) 6
female (6) 6
hemic and immune systems (6) 6
male (6) 6
myeloid leukemia (6) 6
research (6) 6
treatment outcome (6) 6
analysis (5) 5
benzothiazoles - pharmacokinetics (5) 5
dose-response relationship, drug (5) 5
flt3-itd (5) 5
fluids and secretions (5) 5
lestaurtinib (5) 5
leukemia, myeloid, acute - mortality (5) 5
leukemia, myeloid, acute - pathology (5) 5
medicine & public health (5) 5
phenylurea compounds - pharmacokinetics (5) 5
protein kinase inhibitors - chemistry (5) 5
review (5) 5
ac220 (4) 4
benzothiazoles - adverse effects (4) 4
benzothiazoles - chemistry (4) 4
cell line, tumor (4) 4
drug resistance, neoplasm (4) 4
gemtuzumab ozogamicin (4) 4
leukemia, myeloid, acute - enzymology (4) 4
leukemia, myeloid, acute - therapy (4) 4
metabolites (4) 4
middle aged (4) 4
patients (4) 4
pharmacokinetics (4) 4
pharmacology (4) 4
phenylurea compounds - adverse effects (4) 4
phenylurea compounds - chemistry (4) 4
protein-tyrosine kinase (4) 4
resistance (4) 4
acute myeloid leukaemia (3) 3
aged (3) 3
antineoplastic agents - chemistry (3) 3
apoptosis - drug effects (3) 3
benzothiazoles - administration & dosage (3) 3
binding sites (3) 3
biochemistry & molecular biology (3) 3
cell biology (3) 3
cell growth (3) 3
cell proliferation - drug effects (3) 3
clinical trials as topic (3) 3
cpx-351 (3) 3
diseases (3) 3
drug dosages (3) 3
flt3 inhibitors (3) 3
flt3 protein (3) 3
hematology, oncology and palliative medicine (3) 3
leukemia, myeloid, acute - diagnosis (3) 3
leukemia, myeloid, acute - metabolism (3) 3
mice (3) 3
neutropenia (3) 3
oncology, experimental (3) 3
original (3) 3
original article (3) 3
phenylurea compounds - administration & dosage (3) 3
phosphorylation (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Therapeutic advances in hematology, ISSN 2040-6215, 02/2019, Volume 10, pp. 204062071982731 - 2040620719827310
Mutations in the fms-like tyrosine kinase 3 (FLT3) gene are detected in approximately one-third of patients with newly diagnosed acute myeloid leukemia (AML).... 
Life Sciences & Biomedicine | Hematology | Science & Technology | FDA approval | Mutation | Kinases | Leukemia | Regulatory approval
Journal Article
Clinical cancer research, ISSN 1557-3265, 12/2014, Volume 21, Issue 6, pp. 1360 - 1372
Journal Article
Therapeutic advances in hematology, ISSN 2040-6215, 11/2019, Volume 10, pp. 204062071988266 - 2040620719882666
FMS-like tyrosine kinase 3 ( FLT3) mutations are one of the most frequently encountered genetic alterations in acute myeloid leukemia (AML), and are generally... 
Life Sciences & Biomedicine | Hematology | Science & Technology | Transplants & implants | Kinases | Mutation
Journal Article
Cancers, ISSN 2072-6694, 06/2020, Volume 12, Issue 7, p. 1737
Given the proven importance of the CXCL12/CXCR4 axis in the stroma–acute myeloid leukemia (AML) interactions and the rapid emergence of resistance to FLT3... 
quizartinib | CXCR4 | acute myeloid leukemia | FLT3-ITD | LY2510924
Journal Article
Critical reviews in oncology/hematology, ISSN 1040-8428, 09/2019, Volume 141, pp. 125 - 138
Internal tandem duplications and tyrosine kinase mutations in the fms-like tyrosine kinase 3 (FLT3) receptor can occur in acute myeloid leukemia (AML) and... 
AML | Crenolanib | FLT3 | Sorafenib | Midostaurin | Quizartinib | FLT3 inhibitor | Gilteritinib | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Tyrosine | Medical colleges | Chemotherapy | Drug approval | Pharmacy | Cancer | Index Medicus
Journal Article
Oncotarget, ISSN 1949-2553, 03/2020, Volume 11, Issue 11, pp. 943 - 955
internal tandem duplication (ITD) mutations are associated with poor prognosis in patients with acute myeloid leukemia (AML). In this preclinical study, we... 
Journal Article